For COVID-19, small seems to be beautiful. First we had BioNTech, a tiny operation headed by a Turkish immigrant couple in Germany that gave us the Pfizer vaccine. Now along comes a small Maryland biotechnology company, Novavax, finally joining...
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi
A large-scale efficacy trial of a promising tuberculosis (TB) vaccine will soon launch with substantial backing from two major philanthropies. The vaccine, dubbed M72, has so...
